Andere Sprachen Cytophage Technologies Ltd.

Aktien

A4ZZ0X

CA2328211081

CYTO

Markt geschlossen - Toronto S.E. Andere Börsenplätze 21:59:34 22.05.2024			% 5 Tage	% 1. Jan.
0,51 ^CAD	-5,56 %		+24,39 %	-27,62 %

30.04.	Cytophage Technologies Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
16.04.	Cytophage Technologies Ltd. ernennt Michael D. Cochrane zum neuesten Mitglied des Verwaltungsrats	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Cytophage Announces Fiscal Year End 2023 Results	30.04.
Cytophage Technologies Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	30.04.
Cytophage Technologies Ltd. Appoints Michael D. Cochrane as Newest Member of Board of Directors	16.04.
Cytophage Appoints New Board Director	16.04.
Cytophage Technologies Ltd. Provides Update on Bacteriophage Human Trial at The Ottawa Hospital	02.04.
Cytophage Provides Update on Bacteriophage Human Trial at The Ottawa Hospital	02.04.
Cytophage Provides Bacteriophages for Landmark Treatment of Joint Replacement Infection in Canada	01.03.
Cytophage Technologies Ltd. Provides Update on Upcoming Product for Egg Production in Canada	12.02.
Cytophage Update on Upcoming Product for Egg Production in Canada	12.02.
Cytophage Technologies Inc. completed the acquisition of Cuspis Capital III Ltd. (TSXV:CIII.P) in a reverse merger transaction.	02.02.
Cuspis Capital III Ltd. Announces Closing of Concurrent Financing by Cytophage Technologies Inc., Receipt of TSXV Conditional Approval, and Certain Loans	23.12.
Cuspis Capital III Ltd. announced that it has received CAD 2.5 million in funding	22.12.
Cuspis Capital III Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	29.11.
Cuspis Capital III Ltd. and Cytophage Technologies Inc. Announce Execution of Business Combination Agreement and Concurrent Financing	06.11.
Cytophage Technologies Ltd. announced that it expects to receive CAD 2.5 million in funding	06.11.
Cuspis Capital III Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	28.08.23
Canadian Investment Regulatory Organization Trading Halt - CIII.P	01.06.23
Cytophage Technologies Inc. entered into a letter of intent to acquire Cuspis Capital III Ltd. (TSXV:CIII.P) in a reverse merger transaction.	01.06.23
Cytophage Technologies Inc. announced that it expects to receive $5 million in funding from Cuspis Capital III Ltd.	01.06.23
Cuspis Capital III Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	30.05.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Cytophage Technologies Ltd.

Aktien

A4ZZ0X

CA2328211081

CYTO

Andere Sprachen

Filter